⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

TXG

10x Genomics, Inc.

Healthcare · Medical Devices

71.55USD

+1.8000 (+2.58%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TXG.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 71.55
P/E—
Dvd Ind Yld0.0%
P/B11.29
P/S15.1
Curr EV/T12M EBITDA-214.8
Mkt Cap (USD)9.3B
Curr EV (USD)8.8B
2)

Per Share Data

EPS T12M-0.59
DPS—
Bk Val Per Sh6.34
Rev/Sh4.75
Cash/Sh4.24
Curr Shares Out120.2M
FCF/Sh0.93
3)

Cash Flow Analysis

P/CF73.4
Curr P/FCF76.8
CF/NI-1.7
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales20.6%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr77.0%
Cap 1Y Gr12.1%
BPS 1Y Gr8.3%
R&D To Sales—
Retention Rate—
Rev 1Y Gr5.2%
FCF 1Y Gr2371.2%
Assets 1Y Gr13.4%
5)

Profitability

EBITDA-0.0B
EBIT-0.1B
Operating Margin-14.3%
Pretax Margin-12.1%
Net Margin-12.2%
ROA-7.5%
ROE-9.4%
ROC—
Asset Turnover0.61
6)

Structure

Current Ratio5.69
Quick Ratio5.09
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA10.38
Tot Debt/Capital0.0%
Gross Margin70.0%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.